Changmao Biochemical Engineering Company Limited provided group earnings guidance for the six months ended 30 June 2018. The group is likely to record a significant increase in the consolidated net profits for the six months ended 30 June 2018 as compared with the consolidated net profits for the six months ended 30 June 2017. The Board believes that such expected increase in the consolidated net profits was mainly due to the increase in profit margin of the group resulted from the increase in average selling price of some major organic acid products compared to that in the corresponding period in 2017.